Margrit Wiesendanger - Rheumatology | Mount Sinai

About Me

Dr. Wiesendanger is a graduate of the Albert Einstein College of Medicine in the Bronx, NY, where she earned a dual MD-PhD degree in the discipline of Immunology. She then completed a residency in Internal Medicine and fellowship in Rheumatology at the New York-Presbyterian Hospital/Columbia campus. She is board certified in both Rheumatology and Internal Medicine. She served on the faculty in the Division of General Medicine at NYPH-Columbia before joining the Division of Rheumatology at Mount Sinai Hospital in April 2015. Her patient care activities include the Mount Sinai Faculty Faculty Practice Associates and the Center for Advanced Medicine. She is the current Program Director for the rheumatology fellowship. She has received several awards, including the prestigious Daniel V. Kimberg Memorial Junior Faculty Teaching Award and the Ewig Clinical Scholar Award.

Language

English, French, Spanish

Position

ASSOCIATE PROFESSOR | Medicine, Rheumatology

Hospital Affiliations

Mount Sinai Queens
The Mount Sinai Hospital

Research Topics

Autoimmunity, B Cells, Cellular Immunity, Immunological Tolerance, Immunosuppression, Inflammation, Lupus Nephritis, T Cells

Clinical Focus

Ankylosing Spondylitis
Arthritis
Arthrocentesis
Behcet's Disease
Dermatomyositis
Gout
Joint Pain
Osteoarthritis
Polymyalgia Rheumatica And Giant Cell Arteritis

Education

MD, Albert Einstein College of Medicine

Residency, Internal Medicine

Columbia University Irving Medical Center

Fellowship, Rheumatology

Columbia University Irving Medical Center

Certifications

American Board of Internal Medicine

Awards

2013

Ewig Clinical Scholar Award

Columbia University Medical Center, New York, NY

2012

Daniel V. Kimberg Junior Faculty Teaching Award and Lecture

Columbia University Medical Center, New York, NY

2010

Ambulatory Teacher of the Year

Columbia University Medical Center, New York, NY

2000

Elected Member, AOA

Alpha Omega Alpha Honor Medical Society

Research

Dr. Wiesendanger is a co-investigator in the Embrace Study: a phase 3/4, multi-center, randomized, double-blind, placebo-controlled, 52-week study to evaluate the efficacy and safety of belimumab (HGS1006) in adult subjects of black race with systemic lupus.

Locations

17 East 102nd Street, 2nd Floor, New York, NY, 10029

212-241-1671

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.

17 East 102nd Street, 2nd Floor, New York, NY, 10029

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Publications:7

Selected Publications

View All Publications

Patient Experience Star Ratings and Comments

The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.

Care Provider’s Explanation

4.9 out of 5

Care Provider’s Concern

5 out of 5

Likelihood to Recommend Care Provider

5 out of 5

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Wiesendanger during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Board Service

New York State Rheumatology Society
Jewish Community Project Downtown

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Arthritis Advisory Committee (FDA)

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Margrit Wiesendanger, MD, PhD

Rheumatology

About Me

Language

Position

Hospital Affiliations

Research Topics

About Me

Language

Position

Hospital Affiliations

Research Topics

Clinical Focus

Education

MD, Albert Einstein College of Medicine

Residency, Internal Medicine

Fellowship, Rheumatology

Certifications

American Board of Internal Medicine

Awards

Research

Locations

Insurance Information

Publications

Selected Publications

Patient Experience Star Ratings and Comments ?

Care Provider’s Explanation

Care Provider’s Concern

Likelihood to Recommend Care Provider

Industry Relationships

Patient Experience Star Ratings and Comments